{"id":"W4387751226","doi":"10.14309/01.ajg.0000953088.36331.ca","title":"S862 Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naïve Patients With Early Crohn’s Disease: Results From the EVOLVE Expansion Study","year":2023,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thermo Fisher Scientific (Canada); St. Paul's Hospital","funders":"","keywords":"Medicine; Vedolizumab; Discontinuation; Ustekinumab; Internal medicine; Adverse effect; Hazard ratio; Surgery; Crohn's disease; Disease; Infliximab; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006402317,0.0002828554,0.0009264898,0.0003905512,0.0002323676,0.000826269,0.000300127,0.0003617916,0.001888666],"category_scores_gemma":[0.005672196,0.0001595799,0.001316728,0.0008173956,0.0003632985,0.0005563736,0.0005781113,0.0004325325,0.0002539968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005550684,"about_ca_system_score_gemma":0.0007093066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008231943,"about_ca_topic_score_gemma":0.001647773,"domain_scores_codex":[0.9964515,0.002051203,0.0004141832,0.000287256,0.0006842761,0.0001114944],"domain_scores_gemma":[0.9924791,0.002667892,0.003403548,0.0004194058,0.000616248,0.0004137575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08006477,0.002598613,0.8275315,0.001628664,0.004488645,0.0001850744,0.0003606793,0.001588912,0.002821628,0.0002206359,0.00238914,0.07612181],"study_design_scores_gemma":[0.01176868,0.01972525,0.9576614,0.00031426,0.002042983,0.000530663,0.0001495554,0.001439932,0.001533733,0.0001451207,0.004649864,0.00003857864],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935126,0.002358483,0.0001819733,0.0001043609,0.00001120386,0.0001910215,0.002394714,0.000008659766,0.001236901],"genre_scores_gemma":[0.9932318,0.0007000083,0.0005499233,0.0001661869,0.00005464589,0.0002204089,0.004733973,0.000004499211,0.0003384822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006402317,"threshold_uncertainty_score":0.03385907,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008484446606095104,"score_gpt":0.270278579495828,"score_spread":0.2617941328897329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}